Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients
Description
CONCLUSION: We describe the anti-inflammatory impact of dexamethasone on the pathways contributing to cytokine hyperresponsiveness observed in severe manifestations of COVID-19, including type I/II IFN signaling. Dexamethasone could have adverse
